Identification of Human Single-Domain Antibodies against SARS-CoV-2

The worldwide spread of COVID-19 highlights the need for an efficient approach to rapidly develop therapeutics and prophylactics against SARS-CoV-2. The SARS-CoV-2 spike protein, containing the receptor-binding domain (RBD) and S1 subunit involved in receptor engagement, is a potential therapeutic t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Host Microbe
Autori principali: Wu, Yanling, Li, Cheng, Xia, Shuai, Tian, Xiaolong, Kong, Yu, Wang, Zhi, Gu, Chenjian, Zhang, Rong, Tu, Chao, Xie, Youhua, Yang, Zhenlin, Lu, Lu, Jiang, Shibo, Ying, Tianlei
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier Inc. 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7224157/
https://ncbi.nlm.nih.gov/pubmed/32413276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chom.2020.04.023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi